STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Title
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
Authors
Keywords
KRAS Mutation, Pancreatic Ductal Adenocarcinoma, Homozygous Deletion, Tumor Suppressor Role, Pancreatic Ductal Adenocarcinoma Cell
Journal
Genome Medicine
Volume 6, Issue 1, Pages 9
Publisher
Springer Nature
Online
2014-01-31
DOI
10.1186/gm526

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started